Viveve Medical, Inc. Overview
Pro stress-test →Viveve Medical designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence through its Viveve System, which comprises a radiofrequency generator, reusable handpiece, and treatment tip with cryogen canister. The company serves a niche women's health market with patented cryogen-cooled monopolar radiofrequency technology.
Strategic Profile
Pro stress-test →Viveve markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. The company is transitioning from NASDAQ to OTC markets, reflecting significant operational challenges and a severe deterioration in market valuation from historical levels.
Competitive Landscape
Pro stress-test →Viveve operates in the women's health medical device space with competitors in non-invasive gynecological treatments and radiofrequency-based aesthetic devices. The company's market position has severely deteriorated as evidenced by its delisting to OTC markets and near-zero market capitalization. Competitors include larger medical device companies with broader product portfolios and stronger balance sheets.
Industry Context
Viveve Medical, Inc. operates in Medical Devices - Women's Health.
Key facts
Founded: 2005 · Headquarters: Englewood, Colorado · Employees: 47 · Revenue: ~$6.4M (2021) · Market cap: <0.01M